Managing Director
Jan Kruse Hansen
Astion Pharma is a Danish manufacturer of specialised skincare for treatment of eczema and dry skin. The company’s products are registered medical devices approved for the treatment of atopic dermatitis, seborrheic dermatitis and contact eczema with clinically documented effect.
The products are marketed in Denmark through pharmacies and drug stores (Matas) as well as online via the company’s own webshop. Further, a selected range of the products are available through similar channels in near export markets.
The product range includes, in addition to the medical devices for treatment of eczema, a range of nurturing and moisturising skincare products in the form of lotions, ointments, sprays, cleansing gels, dietary supplements, and more. All products contain the patented active ingredient Dermadexin, which treats redness and itching caused by a breakdown of the natural barrier of the skin due to eczema.
The Astion Pharma products are marketed and distributed by the skincare brand Australian Bodycare. Accordingly, the daily management of Astion Pharma is provided by the management of Australian Bodycare.
Read about the company: